Pathology of the motor-sensory axonal guillain-barré syndrome

Annals of Neurology

Volumn 39, Issue 1, 1996, Pages 17-28

  Griffin, J W ^a   Li, C Y ^b   Ho, T W ^a   Tian, M ^a   Gao, C Y ^b   Xue, P ^a   Mishu, B ^c   Cornblath, D R ^a   Macko, C ^a   McKhann, G M ^a,e   Asbury, A K ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOPSY; CAMPYLOBACTER JEJUNI; CASE REPORT; DEMYELINATION; DORSAL ROOT; FEMALE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NERVE DEGENERATION; ONSET AGE; PERIPHERAL NERVE; PRESCHOOL CHILD; PRIORITY JOURNAL; REMYELINIZATION; SPINAL ROOT; VENTRAL ROOT;

ACUTE DISEASE; ADULT; AUTOPSY; AXONS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; PROSPECTIVE STUDIES;

EID: 0030065669     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390105     Document Type: Article

References (56)

1. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome. A clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141
2. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215
3. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3: 565-566
4. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24
5. Brown W, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 1984;107:219-239
6. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
7. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192
8. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 1984;107:219-239
9. Triggs WJ, Cros D, Gominak SC, et al. Motor nerve inexcit-ability in Guillain-Barré syndrome. Brain 1992;115:1291-1302
10. Berciano J, Coria F, Monton F, et al. Axonal form of Guillain-Barré syndrome, evidence for macrophage-associated demyelination. Muscle Nerve 1993;16:744-751
11. Vriesendorp FJ, Mishu B, Blaser M, Koski CL. Serum antibod ies to GM1, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135
12. Fuller GN, Jacobs JM, Lewis PD, Lane RJM. Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement. J Neurol Neurosurg Psychiatry 1992;55:1079-1083
13. Hahn AF, Feasby TE, Steele A, et al. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on myelin dosage. Lab Invest 1988;59:115-126
14. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acuce flaccid paralysis in China. Ann Neurol 1993;33:333-342
15. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
16. Ropper AH. Severe acute Guillain-Barré syndrome. Neurology 1986;36:429-432
17. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immun 1994;62:2101-2103
18. Yuki N, Yamada M, Sato S, et al. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993;16:642-647
19. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 1995;118:577-595
20. 1 antibodies following Campylobacter jejuni enteritis. Neurology 1990;40:1900-1902
21. 1a antibodies. Muscle Nerve 1992;15:899-903
22. Royal W III, Seines OA, Concha M, et al. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann Neurol 1994;36:32-39
23. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (in press)
24. Asbury AK, Johnson PC. Pathology of peripheral nerve. Philadelphia: WB Saunders, 1978
25. Mishu B, Amjad AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-953
26. Prineas JW. Acute idiopathic polyneuritis. An electron microscope study. Lab Invest 1972;26:133-147
27. Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol 1981,9(suppl):6-19
28. Honavar M, Tharakan JKJ, Hughes RAC, et al. A clinicopathological study of the Guillain-Barré syndrome. Brain 1991;114: 1245-1269
29. 1 antibodies in Guillain-Barré syndrome and their relationship to campylobacter jejuni infection. Ann Neurol 1995;38:809-816
30. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. 2. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618
31. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
32. Griffin JW, Ho TW. The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol 1993;34:125-127 (Editorial)
33. Griffin JW, Stoll G, Li CY, et al. Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 1990; 27(suppl):S64-S68
34. Brechenmacher C, Vital C, Laurentjoye L, Castaing Y. Ultra-structural study of peripheral nerve in Guillain-Barré syndrome. Presence of mononuclear cells in axons. Acta Neuropathol (Berl) 1981;7(suppl):249-251
35. Brechenmacher C, Vital C, Deminiere C, et al. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 1987;6:19-24
36. Franson P, Ronnevi L-O. Myelin breakdown and elimination in the posterior funiculus of the adult cat after dorsal rhizotomy: a light and electron microscopic qualitative and quantitative study. J Comp Neurol 1984;223:138-151
37. George R, Griffin JW. Delayed macrophage responses and myelin clearance during wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 1994; 129:225-236
38. George R, Griffin JW. The proximo-distal spread of axonal regeneration in the dorsal columns of the rat. J Neurocytol 1994;23:657-667
39. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia ataxia and areflexia). N Engl J Med 1956;255:57-65
40. Yuki N, Sato S, Fujimoto S, et al. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve 1992;16:968-969
41. Ernfors P, Lee K-F, Kucera J, et al. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-512
42. Gregson NA, Jones D, Thomas PK, Willison HJ. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol 1991;238:447-451
43. Illa L Orriz N, Gallard E, et al. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 1995;38:218-224
44. Willison Hj, Veitch J, Patterson G, Kennedy PGE. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside J Neurol Neurosurg Psychiatry 1993;56:204-206
45. Yuki N, Sato S, Tsuji S, et al. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993;43:414-417
46. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neurochem 1994;50:159-165
47. Ganser AL, Kirschner DA, Willinger M. Ganglioside localization on myelinated nerve fibres by cholera toxin binding. J Neurocytol 1983;12:921-938
48. Ganser AL, Kirschner DA. Differential expression of gangliosides on the surfaces of myelinated nerve fibers. J Neurosci Res 1984;12:245-255
49. Thomas FP, Adapon HP, Goldberg GP, et al. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease. J Neuroimmunol 1989;21:31-39
50. 1 antibodies, and multifocal motor conduction block. Ann Neurol 1990;28:373-377
51. Corbo M, Quattrini A. Latov N, Hays AP. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809-814
52. Apostolski S, Sadiq SA, Hays A, et al. Identification of Gal(betal-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 1994;38:134-141
53. Roberts M, Willison HJ, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995;38:111-118
54. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442
55. Yuki N, Sato S, Itoh T, Miyatake T. HLA-B35 and acute axonal polyneuropathy following Campylobacter jejuni infection. Neurology 1991;41:1561-1563
56. Macko C, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (in press)